Your source for biosimilars information, including: the basics, value, approval, manufacturing, and prescribing
Last updated August 2019

Article

The Potential Benefits and Advantages of Biosimilars

Biosimilars cost savings: a valuable impact on health care cost

Biosimilars are expected to have a robust impact on lowering health care costs

Biosimilars are expected to save the EU up to $44B in health care costs by 2020.¹
Over the next five to 10 years in the US, it is estimated that biosimilars can save the health care system approximately $150B.²

The value of biosimilars in the marketplace

Biosimilars offer the opportunity for system-wide cost savings.
The introduction of biosimilars can provide headroom for greater investment in innovator products.
Biosimilars can provide more treatment options to patients with serious illnesses.

The value of biosimilars

Related articles and links:

References: 1. Inside Sources. Europe Demonstrates Benefits of a Strong Biosimilars Marketplace. www.insidesources.com/europe-demonstrates-benefits-strong-biosimilars-marketplace/. Accessed December 21, 2018. 2. Grewal S, Ramsay S, Balu S, Carlson JJ. Cost-savings for biosimilars in the United States: a theoretical framework and budget impact case study application using filgrastim. Expert Rev of Pharmacoecon Outcomes Res. 2018;18:447-454. 3. The Biosimilars Council. Biosimilars in the United States. Providing More Patients Greater Access to Lifesaving Medicines. www.biosimilarscouncil.org/wp-content/uploads/2017/09/Biosimilars-Council-Patient-Access-Study_090917.pdf. Accessed December 21, 2018.